SLN- and NLC-encapsulating antifungal agents: skin drug delivery and their unexplored potential for treating onychomycosis.
SLN- and NLC-encapsulating antifungal agents: skin drug delivery and their unexplored potential for treating onychomycosis.
Taís Gratieri,Anna Paula Krawczyk-Santos,4 Authors,S. Taveira
2018 · DOI: 10.2174/1381612823666171115112745
Current pharmaceutical design · 27 Citations
TLDR
Evidence of the success of SLN and NLC in achieving high encapsulation efficiencies of antifungals and promoting cutaneous delivery indicates the potential of the systems in enhancing nail hydration and drug penetration into the nail plate.